Talis Biomedical Corporation (TLIS)

USD 1.6

(6.67%)

Gross Profit Summary of Talis Biomedical Corporation

  • Talis Biomedical Corporation's latest annual gross profit in 2023 was 371 Thousand USD , up 0.76% from previous year.
  • Talis Biomedical Corporation's latest quarterly gross profit in 2024 Q2 was -84 Thousand USD , up 56.92% from previous quarter.
  • Talis Biomedical Corporation reported a annual gross profit of -4.73 Million USD in annual gross profit 2022, down -80.81% from previous year.
  • Talis Biomedical Corporation reported a annual gross profit of -2.62 Million USD in annual gross profit 2021, down -123.96% from previous year.
  • Talis Biomedical Corporation reported a quarterly gross profit of -84 Thousand USD for 2024 Q2, up 56.92% from previous quarter.
  • Talis Biomedical Corporation reported a quarterly gross profit of -471 Thousand USD for 2023 Q4, down -772.86% from previous quarter.

Annual Gross Profit Chart of Talis Biomedical Corporation (2023 - 2018)

Historical Annual Gross Profit of Talis Biomedical Corporation (2023 - 2018)

Year Gross Profit Gross Profit Growth
2023 371 Thousand USD 0.76%
2022 -4.73 Million USD -80.81%
2021 -2.62 Million USD -123.96%
2020 10.93 Million USD 175.03%
2019 3.97 Million USD 66.4%
2018 2.39 Million USD 0.0%

Peer Gross Profit Comparison of Talis Biomedical Corporation

Name Gross Profit Gross Profit Difference
Acutus Medical, Inc. -3.13 Million USD 111.827%
Biotricity, Inc. 8.35 Million USD 95.56%
Cell MedX Corp. - USD -Infinity%
Dynatronics Corporation 7.63 Million USD 95.141%
Nemaura Medical Inc. -1.47 Million USD 125.129%
PetVivo Holdings, Inc. 739.52 Thousand USD 49.833%
RetinalGenix Technologies Inc. -100.00 USD 371100.0%
Sonendo, Inc. 10.72 Million USD 96.54%
Telesis Bio, Inc. 16.95 Million USD 97.811%
Viveve Medical, Inc. 620 Thousand USD 40.161%